Home
About Us
Background
Investment Strategy
Team
Portfolio
News
Contact
中文
Investor Login
Home
About Us
Background
Investment Strategy
Team
Portfolio
News
Contact
中文
Investor Login
We are Company Builders
Identifying, incubating and growing future industry leaders in life sciences.
We are Industry Veterans
Capturing evolving healthcare trends and emerging cutting-edge innovations
We are Preferred Partners
Connecting companies with extensive network and resources globally and in China
Windward Bio Doses First Patients in Phase 2 SIRIUS COPD Study of Ultra Long- Acting Anti-TSLP Antibody WIN378
...
June 9, 2026
OriCell’s GPC3 CAR-T Receives NMPA Clearance for Confirmatory Phase II Trial in Late-Line Advanced Hepatocellular Carcinoma
...
June 8, 2026
China NMPA Grants IND Clearance to Adcentrx Therapeutics’ ADRX-0405 STEAP1 ADC for the Treatment of Late-Stage Solid Tumors, Including Prostate Cancer
...
June 8, 2026
All news